2022 NICE 技术鉴定指南:奥扎尼莫德用于治疗中度至重度活动性溃疡性结肠炎 [TA828]

2022-10-05 英国国家卫生与临床优化研究所 NICE官网

当常规或生物治疗不能耐受或效果不佳时,关于奥扎尼莫德(Zeposia) 治疗成人中度至重度活动性溃疡性结肠炎的循证建议。

中文标题:

2022 NICE 技术鉴定指南:奥扎尼莫德用于治疗中度至重度活动性溃疡性结肠炎 [TA828]

英文标题:

Ozanimod for treating moderately to severely active ulcerative colitis Technology appraisal guidance [TA828]

发布日期:

2022-10-05

简要介绍:

当常规或生物治疗不能耐受或效果不佳时,关于奥扎尼莫德(Zeposia) 治疗成人中度至重度活动性溃疡性结肠炎的循证建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=ozanimod-for-treating-moderately-to-severely-active-ulcerative-colitis-pdf-82613377539781.pdf)] GetToolGuiderByIdResponse(projectId=1, id=843991c002e08099, title=2022 NICE 技术鉴定指南:奥扎尼莫德用于治疗中度至重度活动性溃疡性结肠炎 [TA828], enTitle=Ozanimod for treating moderately to severely active ulcerative colitis Technology appraisal guidance [TA828], guiderFrom=NICE官网, authorId=0, author=, summary=当常规或生物治疗不能耐受或效果不佳时,关于奥扎尼莫德(Zeposia) 治疗成人中度至重度活动性溃疡性结肠炎的循证建议。, cover=https://img.medsci.cn/202201006/1665031794656_5579292.png, journalId=0, articlesId=null, associationId=2005, associationName=英国国家卫生与临床优化研究所 , associationIntro=英国国家卫生与临床优化研究所 (NICE,National Institute for Health and Clinical Excellence), copyright=0, guiderPublishedTime=Wed Oct 05 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #0e0e0e; font-size: 14px;">当常规或生物治疗不能耐受或效果不佳时,关于奥扎尼莫德</span><span style="font-size: 14px;"><span style="color: #0e0e0e;">(Zeposia) 治疗成人中度至重度活动性溃疡性结肠炎的</span><span style="color: #005ea5;">循证建议。</span></span></p>, tagList=[TagDto(tagId=92656, tagName=活动性溃疡性结肠炎), TagDto(tagId=462923, tagName=奥扎尼莫德)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1879, appHits=43, showAppHits=0, pcHits=460, showPcHits=1836, likes=0, shares=12, comments=0, approvalStatus=1, publishedTime=Wed Oct 12 20:28:00 CST 2022, publishedTimeString=2022-10-05, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=7, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Oct 06 12:50:33 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Fri Jan 05 18:10:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=ozanimod-for-treating-moderately-to-severely-active-ulcerative-colitis-pdf-82613377539781.pdf)])
ozanimod-for-treating-moderately-to-severely-active-ulcerative-colitis-pdf-82613377539781.pdf
下载请点击:
评论区 (0)
#插入话题